NCT00293423 2021-05-13
GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma
University of California, San Francisco
Phase 1/2 Completed
Clinical Trials
6 trialsNCT00905060 2021-03-24
HeatShock
University of California, San Francisco
Phase 2 Completed
NCT00003025 2013-07-03
Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00005628 2013-06-19
Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT00039000 2012-09-07
Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma
Agenus Inc.
Phase 3 Completed
NCT00098085 2009-03-09
Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer
Agenus Inc.
Phase 2 Completed